Margaret Smith Bell - 05 Feb 2025 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris, Attorney-in-Fact
Issuer symbol
TNXP
Transactions as of
05 Feb 2025
Net transactions value
-$0.15
Form type
4
Filing time
28 Feb 2025, 17:32:22 UTC
Previous filing
24 May 2024
Next filing
15 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNXP Common Stock, par value $0.001 Other $0.15 -1 -100% $0.1500 0 05 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock.